Momenta Pharmaceuticals to Webcast Presentation at the Canaccord Genuity Growth Conference
July 30 2014 - 04:05PM
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, today announced that its presentation at the
Canaccord Genuity Growth Conference will be webcast on Thursday,
August 14 at 4:00 p.m. ET.
The audio webcast of the presentation will be available live on
the "Investors" section of the company's website located at
www.momentapharma.com. A replay of the presentation will be posted
on the Momenta website approximately one hour after the event and
will be available for two weeks following the presentation.
About Momenta Momenta Pharmaceuticals is a
biotechnology company specializing in the detailed structural
analysis of complex mixture drugs and is headquartered in
Cambridge, MA. Momenta is applying its technology to the
development of generic versions of complex drugs, biosimilar and
potentially interchangeable biologics, and to the discovery and
development of novel products.
To receive additional information about Momenta, please visit
the website at www.momentapharma.com, which does not form a part of
this press release.
CONTACT: Momenta Pharmaceuticals, Inc.
ir@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2023 to Mar 2024